These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


629 related items for PubMed ID: 22614937

  • 1. Erectile dysfunction among male heroin addicts receiving methadone maintenance treatment in Guangdong, China.
    Chen W, Li X, Li X, Ling L, Xia Y, Chen J, He Q.
    J Addict Med; 2012 Sep; 6(3):212-8. PubMed ID: 22614937
    [Abstract] [Full Text] [Related]

  • 2. Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment.
    Quaglio G, Lugoboni F, Pattaro C, Melara B, G.I.C.S, Mezzelani P, Des Jarlais DC, G.I.C.S.
    Drug Alcohol Depend; 2008 Apr 01; 94(1-3):12-8. PubMed ID: 18083312
    [Abstract] [Full Text] [Related]

  • 3. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW, Wu HC, Yen CN, Yeh YC, Chung KS, Chang HC, Yen CF.
    Am J Drug Alcohol Abuse; 2012 May 01; 38(3):213-9. PubMed ID: 22352836
    [Abstract] [Full Text] [Related]

  • 4. Sexual function of 612 male addicts treated by methadone.
    Zhang Y, Wang P, Ma Z, Xu Z, Li Y.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Aug 01; 36(8):739-43. PubMed ID: 21937799
    [Abstract] [Full Text] [Related]

  • 5. Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China.
    Li L, Sangthong R, Chongsuvivatwong V, McNeil E, Li J.
    Drug Alcohol Depend; 2011 Jul 01; 116(1-3):246-9. PubMed ID: 21282020
    [Abstract] [Full Text] [Related]

  • 6. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW, Wu HC, Yen CN, Yeh YC, Chung KS, Chang HC, Yen CF.
    Psychol Addict Behav; 2012 Mar 01; 26(1):145-50. PubMed ID: 21859169
    [Abstract] [Full Text] [Related]

  • 7. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K.
    J Psychiatr Pract; 2009 May 01; 15(3):227-34. PubMed ID: 19461397
    [Abstract] [Full Text] [Related]

  • 8. [Risk factors which were associated with heroin use during the methadone maintenance treatment among 1301 patients in 9 cities of China.].
    Cao XB, Yin WY, Pang L, Zhang CB, Xu JS, Xiao YK, Wang CH, Luo W, Zhang B, Zhang RM, Li ZJ, Rou KM, Wu ZY.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Mar 01; 31(3):269-72. PubMed ID: 20510050
    [Abstract] [Full Text] [Related]

  • 9. Sexual dysfunction during methadone maintenance treatment and its influence on patient's life and treatment: a qualitative study in South China.
    Xia Y, Zhang D, Li X, Chen W, He Q, Jahn HJ, Li X, Chen J, Hu P, Ling L.
    Psychol Health Med; 2013 Mar 01; 18(3):321-9. PubMed ID: 23092392
    [Abstract] [Full Text] [Related]

  • 10. Familial expressed emotion among heroin addicts in methadone maintenance treatment: does it matter?
    Lee CH, Wang TJ, Tang HP, Liu YH, Bell J.
    Addict Behav; 2015 Jun 01; 45():39-44. PubMed ID: 25638535
    [Abstract] [Full Text] [Related]

  • 11. Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.
    Shi J, Zhao LY, Epstein DH, Zhang XL, Lu L.
    Pharmacol Biochem Behav; 2007 May 01; 87(1):141-5. PubMed ID: 17532034
    [Abstract] [Full Text] [Related]

  • 12. [Factors influencing the rate on retention to methadone maintenance treatment program among heroin addicts in Guizhou, China].
    Liang T, Liu EW, Zhong H, Wang B, Shen LM, Wu ZL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb 01; 30(2):131-5. PubMed ID: 19565871
    [Abstract] [Full Text] [Related]

  • 13. Misconceptions toward methadone maintenance treatment (MMT) and associated factors among new MMT users in Guangzhou, China.
    Xu H, Gu J, Lau JT, Zhong Y, Fan L, Zhao Y, Hao C, He W, Ling W.
    Addict Behav; 2012 May 01; 37(5):657-62. PubMed ID: 22353775
    [Abstract] [Full Text] [Related]

  • 14. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J, Garijo I, Siñol N, del Pozo J, Portella MJ, Pérez de los Cobos J.
    Drug Alcohol Depend; 2012 Jun 01; 123(1-3):41-7. PubMed ID: 22071121
    [Abstract] [Full Text] [Related]

  • 15. [Risk factors associated with continued heroin use during methadone maintenance treatment in Guizhou province, China].
    Liu EW, Wu ZY, Liang T, Shen LM, Zhong H, Wang B, Roger D.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Dec 01; 42(12):875-8. PubMed ID: 19141219
    [Abstract] [Full Text] [Related]

  • 16. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E, Schreiber S, Naumovsky Y, Adelson M.
    J Affect Disord; 2007 Apr 01; 99(1-3):213-20. PubMed ID: 17055063
    [Abstract] [Full Text] [Related]

  • 17. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT, Tait RJ, Hulse GK.
    Arch Gen Psychiatry; 2008 Apr 01; 65(4):457-65. PubMed ID: 18391134
    [Abstract] [Full Text] [Related]

  • 18. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM, Grinshpoon A.
    Am J Drug Alcohol Abuse; 2007 Apr 01; 33(5):631-42. PubMed ID: 17891656
    [Abstract] [Full Text] [Related]

  • 19. Self-efficacy and HIV risk behaviors among heroin users in Taiwan.
    Ko NY, Wang PW, Wu HC, Yen CN, Hsu ST, Yeh YC, Chung KS, Yen CF.
    J Stud Alcohol Drugs; 2012 May 01; 73(3):469-76. PubMed ID: 22456252
    [Abstract] [Full Text] [Related]

  • 20. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, Gerra ML, Amore M, Manfredini M, Donnini C, Somaini L.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):483-9. PubMed ID: 21147192
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.